RODINRescues On reperfusion Damage in cerebral Infarction by Nelonemdaz
Phase III clinical study in Korea to verify the improvement and neuroprotective effect of nelonemdaz in 496 patients with acute ischemic stroke undergoing surgery to remove a blood clot within 12 hours following last known normal.
Participating Hospitals (Department of Neurology): 24 University hospitals including Asan Medical Center in Seoul
IND Approval Date: August 2021 (first patient enrolled on December 25, 2021)
Total No. of Enrolled Patients
Progress RateAs of June 7, 2022